WHO Home
WHO Health Systems and Services
WHO Medicines
WHO sites
Medicines Documentation home
Search
Titles A-Z
Subjects
Keywords
Series and Periodicals
Publishers
Authors A-Z
Regions
Countries
Index
A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

K  
Knowledge, skills and attitudes for treatment work

 
 Top of page
L  
Legal status of traditional medicine and complementary/alternative medicine
Legislation and drug registration procedures
Linking treatment and prevention
List of available International Chemical Reference Substances
List of available International Infrared Reference Spectra

 
 Top of page
M  
Maintaining the quality of your products
Management of acute, chronic and recurrent illnesses, and rehabilitation
Management of drug donations by the recipient
Managerial strategies to promote rational drug use
Managing HIV/AIDS-related drugs
Managing the Essential Drug Programme
Marketing authorization procedure for medicinal products
Materials handling equipment and storage media
Measures relating to use of drug subsidy lists and to regulation
Measuring access to antimalarials
Medical products and the internet
Medicines and the new economic environment
The medicines crossing borders project
Medicines for the treatment of hypertension
Methodologies for research and evaluation of herbal medicines
Methodology of drug utilization studies
Model certificate of good manufacturing practices
Model guidelines for the international provision of controlled medicines for emergency medical care
Model guidelines on conflict of interest
Model shipment request/notification form for emergency supplies of controlled substances
Monitoring and assessing country pharmaceutical situations
Monitoring and evaluating HIV/AIDS-related treatment work
Monitoring and evaluating national drug policies
Monitoring and evaluating rational medicines use
Monitoring of adverse drug reactions
Monitoring the impact of globalization and TRIPS on access to essential drugs
Monitoring, training and planning (MTP) strategy for improving rational drug use
Mother to child transmission of HIV: WHO statement
A multidisciplinary approach towards adherence
Multisource (generic) pharmaceutical products

 
 Top of page
N  
Narcotic and psychotropic drugs
National drug policies: what has been learnt?
National drug policy and essential drugs list
National drug regulatory legislation
National training workshops on problem-based pharmacotherapy teaching
National tuberculosis control programmes
The need for critical assessment of new medicines
Network for monitoring the impact of globalization and TRIPS on access to medicines
New initiative to develop drugs for neglected diseases
The new structure of the pharmaceutical industry
NGO toolkit for improving access to HIV/AIDS treatment
Non-patentability: biotechnology-based drugs
The normalisation of the international market for pharmaceuticals
Notification of the trial or submission to the drug regulatory authority

 
 Top of page
O  
Officially designated depository libraries for WHO publications
Operational principles for good pharmaceutical procurement
Orderly arrangement of essential medicines
Overcoming clinical resistance using combinations

 
 Top of page
 

Contacts | E-mail scams | Employment | FAQs | Feedback | Privacy | RSS feeds
© WHO 2013
Last updated: May 3, 2013